![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/135 | (2006.01) |
A61K 31/135 | (2013.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 9/0043 | (2013.01) | ||
A61K 9/08 | (2006.01) | ||
A61K 9/08 | (2013.01) | ||
A61P 25/00 | (2006.01) | ||
A61P 43/00 | (2018.01) | ||
A61P 43/00 | (2006.01) | ||
A61P 25/00 | (2018.01) |
(11) | Number of the document | 3976012 |
(13) | Kind of document | T |
(96) | European patent application number | 20754342.2 |
Date of filing the European patent application | 2020-05-29 | |
(97) | Date of publication of the European application | 2022-04-06 |
(45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2020/000432 |
Date | 2020-05-29 |
(87) | Number | WO 2020/240279 |
Date | 2020-12-03 |
(30) | Number | Date | Country code |
201962855543 P | 2019-05-31 | US |
(72) |
HOLM, Per , DK
PEDERSEN, Ole , DK
KRUSZ, John, Claude , US
|
(73) |
Afyx Development A/S ,
Agern Alle 24, 2970 Hørsholm,
DK
|
(54) | INTRANASAL ADMINISTRATION OF KETAMINE TO CLUSTER HEADACHE PATIENTS |
INTRANASAL ADMINISTRATION OF KETAMINE TO CLUSTER HEADACHE PATIENTS |